BC Week In Review | Oct 3, 2011
Company News

Novagali, Santen deal

Santen will acquire fellow ophthalmic company Novagali for €6.15 per share, or about €100 million ($134.2 million). The price is a 71% premium to Novagali's close of €3.59 on Sept. 27, before the deal was...
BC Extra | Sep 29, 2011
Company News

Santen to acquire Novagali

Santen Pharmaceutical Co. Ltd. (Tokyo:4536; Osaka:4536) will acquire fellow ophthalmic company Novagali Pharma S.A. (Euronext:NOVA) for EUR 6.15 per share, or about EUR 100 million ($134.2 million). The price is a 71% premium to Novagali's...
BC Week In Review | Sep 12, 2011
Clinical News

Catioprost: Phase II data

A single-blind, U.S. Phase II trial in 105 patients with glaucoma or ocular hypertension and ocular surface disease showed that once-daily Catioprost was non-inferior to Travatan Z travoprost in reducing mean IOP at 3 months....
BC Week In Review | Apr 25, 2011
Clinical News

Catioprost: Completed Phase II enrollment

Novagali completed enrollment of 105 patients with glaucoma or ocular hypertension and ocular surface disease in a single-blind, U.S. Phase II trial comparing Catioprost vs. Travatan Z travoprost. The Alcon Inc. division of Novartis AG...
BC Week In Review | Jan 3, 2011
Clinical News

Catioprost: Phase II started

Novagali began a single-blind, U.S Phase II trial to compare Catioprost vs. Travatan Z travoprost in 100 patients with glaucoma or ocular hypertension and ocular surface disease. Alcon Inc. (NYSE:ACL, Hunenberg, Switzerland) markets Travatan Z....
BioCentury | Jul 26, 2010
Finance

Bear out of Hibernation

Dov Pharmaceutical Inc. has been slowing dying for a long time, but its neglected assets are now back in play in newco Euthymics Bioscience Inc. , which VCs financed with $24 million in a tranched series...
BC Week In Review | Mar 16, 2009
Clinical News

Novagali preclinical data

In a toxicological rabbit model, Nova21027 did not induce obvious toxicity to the ocular surface compared with conventional formulations of prostaglandin analogs. The study compared the 0.005% latanoprost in cationic emulsion with benzalkonium chloride (BAC)-containing...
Items per page:
1 - 7 of 7